NMNikolina Marić

Nikolina Marić

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nikolina Marić has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Extracorporeal Cooling in Heat Stroke Induced Takotsubo Cardiomyopathy

    by Maja Mačković, Nikolina Marić, Petar Pekić, Nikola Udiljak, Zrinka Planinić

    Heat stroke is a life‐threatening condition characterized by elevated core body temperature (≥ 40°C) and central nervous system (CNS) dysfunction, resulting from body′s inability to adequately dissipate heat. It can lead to multiorgan failure, including the cardiovascular system. Takotsubo cardiomyopathy (TCM), also known as stress‐induced cardiomyopathy, is an acute syndrome of transient global or regional ventricular dysfunction, most commonly apical ballooning, mimicking acute coronary syndrome, typically occurring after severe physical or emotional stress. Although individually well‐described, the combination of severe heat stroke as a trigger for TCM is rare. This case report describes a female patient with severe heat stroke who developed TCM and, due to persistent hyperthermia unresponsive to conventional cooling methods, was successfully cooled using prolonged intermittent hemodiafiltration. It also highlights the importance of timely recognition of atypical complications such as TCM in patients with cardiovascular instability and demonstrates the potential role of hemodialysis as an effective cooling method in cases of refractory hyperthermia.

  • Open Access

    Acute pancreatitis associated with tacrolimus in a lung transplant recipient: a case report and review of literature

    by Ana Šmaguc, Maja Mačković, Nikolina Marić, Nikola Udiljak

    Background: Tacrolimus is a commonly used immunosuppressant with well-defined side effects, including hypertriglyceridemia and hyperglycaemia. However, acute pancreatitis is still not widely recognized as an adverse event related to tacrolimus. Case presentation: A 60-year-old male was admitted to the intensive care unit with symptoms and signs of acute pancreatitis. He underwent lung transplantation 4 years ago and since then received tacrolimus, mycophenolate mofetil (MMF) and prednisone. His initial laboratory tests revealed elevated serum amylase and lipase, high inflammatory parameters, markedly elevated triglycerides and hyperglycemia with diabetic ketoacidosis. He was treated with continuous insulin infusion, electrolyte correction, crystalloid titration and antimicrobial therapy. During the fasting period, immunosuppression was maintained with parenteral methylprednisolone and tacrolimus. Gradually, oral tacrolimus, MMF and full enteral nutrition were introduced. A control computed tomography scan showed pancreatic body necrosis with a large pseudocyst. The patient was discharged on a strict diet, fenofibrate and short- and long-acting insulin. Immunosuppressive therapy with tacrolimus, MMF and prednisone was continued. He was hospitalized several times within a year due to complications of severe necrotizing pancreatitis. Conclusion: Acute pancreatitis associated with the use of tacrolimus is rare. Factors contributing to its occurrence are longer exposure period, toxic levels of the drug and concurrent metabolic derangements, predominantly hypertriglyceridemia. In this case report we present a patient after lung transplantation on tacrolimus therapy who developed severe acute necrotizing pancreatitis along with hypertriglyceridemia and diabetes mellitus. We also conducted a literature search and found 13 other cases of acute pancreatitis presumably related to tacrolimus therapy.

  • Open Access

    The most common causes of dyspneia in children

    by Nikolina Marić, Milica Odavić, Aleksandar Đuričin, Dane Tabš, Tamara Nocmartini, Milovan Radulović, Nemanja Martić, Aleksandra Opačić, Goran Rakić

    Introduction: Respiratory diseases account for more than 25% of all pediatric examinations. The most common are asthma, acute bronchitis and respiratory infections. They are mostly accompanied by dyspnea, increased body temperature and cough. Objective: To examine the frequency, age differences and seasonal nature of respiratory diseases in the pediatric age. Materials and methods: The data were analyzed retrospectively, using the electronic database of the Novi Sad Emergency Medical Service (EMSNS) in the period from July 1, 2022 to July 1, 2023. The research included pediatric patients diagnosed with laryngitis (J04 according to ICD-10), acute bronchitis (J20 according to ICD-10), asthma (J45 according to ICD-10) and pneumonia (J18 according to ICD-10). 11259 patients of both sexes were analyzed. For data analysis we used descriptive statistical methods and standard deviation. Results: Out of a total of 11,259 examined children, 840 (7%) of them presented with respiratory problems. Of these, there were 519 (62%) boys and 321 (38%) girls. The average age of the children was 4 years (SD ± 3.2). The majority of children examined were aged 0-5 - 644 (77%). 472 (56%) children were diagnosed with laryngitis, 267 (32%) children had acute bronchitis, 81 (10%) children had asthma, 20 children (2%) had pneumonia. Most children were examined in October - 135 (16%), most often due to laryngitis - 73 (54%). 765 (91%) were treated on the spot, while 75 (9%) of them were referred to the IZZDIOV, of which 33 (44%) children were referred for acute bronchitis. The most frequently used therapy was Methylprednisolone - 368 (46%), mostly in 202 (24%) children diagnosed with laryngitis. Conclusion: Prevention, early diagnosis and therapy are necessary in order to prevent more serious complications of these diseases.

  • Hypertriglyceridemia‐induced pancreatitis treated with continuous insulin infusion—Case series

    by Nikolina Marić, Maja Mačković, Miro Bakula, Katarina Mucić, Nikola Udiljak, Marinko Marušić

    Objective: There are no definitive treatment guidelines for hypertriglyceridemia (HTG)‐induced acute pancreatitis (AP). The aim of this retrospective study was to evaluate the efficacy of insulin in decreasing triglyceride (TG) levels in patients with HTG‐induced AP.Design: We included 17 cases of HTG‐induced AP treated with continuous insulin aspart for 4 days.Patients: Fifteen patients were male, two were female. The mean TG level at admission was 56.53 ± 25.29 mmol/L. The mean APACHE II score was 10.2 ± 5.7, Ranson 4.2 ± 1.7 and Balthazar 6.5 ± 2.6, implying a severe form of the disease.Methods: In an 8‐year period, 17 patients with a diagnosis of HTG‐induced AP were treated with a continuous infusion of 5% dextrose and insulin aspart in an attempt to lower TG levels. TG levels were assessed on admission, the second and fourth day of therapy. The patient outcome, complications and recurrence of AP were monitored.Results: A significant reduction of TG levels was observed in all patients on Day 4. All patients survived, with one forming a giant pseudocyst as a disease complication, one needing haemodialyses treatment due to an acute kidney injury, and one developing acute respiratory distress syndrome that required mechanical ventilation for 4 days. All patients recovered completely.Conclusion: Our study showed that continuous insulin aspart infusion decreases TG levels in HTG‐induced AP from a mean TG level of 56.53 mmol/L on Day 1 to 21.75 mmol/L on Day 2 and finally to 6.86 mmol/L on Day 4. We consider this therapy very efficient, safe, simple to administer and monitor.